High-purity Bronchogen is a synthetic bioregulatory peptide evaluated in preclinical models for its role in modulating gene expression and inflammatory cascades. PX1 Research supplies institutional laboratories with USA-manufactured, HPLC-verified Bronchogen accompanied by lot-specific certificates of analysis.
High-purity Bronchogen is a synthetic bioregulatory peptide evaluated in preclinical models for its role in modulating gene expression and inflammatory cascades. PX1 Research supplies institutional laboratories with USA-manufactured, HPLC-verified Bronchogen accompanied by lot-specific certificates of analysis.
When evaluating options to buy Bronchogen cytokine regulation price models vary based on synthetic purity, analytical verification, batch volume, and endotoxin compliance. High-purity research-grade Bronchogen is supplied strictly for in vitro and laboratory research into pulmonary tissue maintenance and inflammatory cytokine expression. Authentic institutional pricing reflects rigorous batch testing via high-performance liquid chromatography and mass spectrometry.
Investigators studying cell signaling in respiratory models require reference-standard materials to ensure reproducibility. PX1 Research provides verified peptide reagents to academic, private, and institutional laboratories, maintaining full analytical transparency for every lot produced.
Bronchogen is a short synthetic peptide chain consisting of four amino acids (Ala-Asp-Glu-Leu). Belonging to the class of short peptide bioregulators originally conceptualized for tissue-specific gene regulation, it is designed to interact directly with chromatin structures and promoter regions of target genes within respiratory epithelial cells.
In physical assays, the peptide exhibits a low molecular weight, high aqueous solubility, and specific binding affinity to nucleosomal DNA. Researchers studying all peptides in the bioregulator class utilize Bronchogen to observe how short amino acid sequences pass through nuclear membranes to influence transcriptional activity without requiring specialized transfection vehicles.
In vitro assays demonstrate that Bronchogen plays a key role in modulating inflammatory pathways by influencing the transcription of inflammatory signaling proteins. Preclinical models of bronchial epithelial tissue show that exposure to Bronchogen correlates with altered expression profiles of pro-inflammatory cytokines, including interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-α).
Data from murine pulmonary models indicate that the peptide promotes homeostasis by downregulating hyperactive inflammatory signaling while preserving protective basal immune responses. This dual action makes it a focal compound in cytokine regulation peptides studies aiming to understand chronic inflammatory pathways in pulmonary tissues.
Laboratory investigation into Bronchogen spans several decades of peptide bioregulator research. Studies utilizing primary human bronchial epithelial cell cultures (HBE) demonstrate that Bronchogen treatment modulates the expression of genes responsible for surfactant protein synthesis and cell-cell junction integrity.
Epigenetic assays suggest that short peptides like Bronchogen bind to specific site motifs in the major groove of DNA, inducing localized chromatin decompaction. In animal models subjected to environmental toxins or stress, Bronchogen administration yielded reductions in neutrophil infiltration into bronchoalveolar lavage fluid (BALF), highlighting its utility as an investigative tool in respiratory cellular dynamics. For a wider repository of trial data, explore the PX1 research hub.
When evaluating the market to buy Bronchogen for experimental protocols, price should always be weighed against analytical verification. Low-cost peptides lacking lot-specific testing frequently contain synthesis byproducts, truncated sequences, or elevated endotoxin levels that compromise cell culture viability and distort quantitative PCR results.
Key pricing drivers for research-grade Bronchogen include synthesis scale, purification steps, and third-party laboratory verification. High-purity Bronchogen (>98% pure by RP-HPLC) manufactured in ISO-certified, GMP-compliant facilities requires robust quality controls. PX1 Research maintains fair, transparent tier pricing for institutional accounts seeking guaranteed sequence fidelity and minimal batch-to-batch variation. Institutional buyers can apply for volume terms via our wholesale portal.
In preclinical pulmonology and immunology research, Bronchogen is frequently compared against other targeted peptides to determine differential tissue specificity and receptor binding pathways.
While Bronchogen targets bronchial mucosal tissue and localized cytokine cascades, Chonluten (Tripeptide Glu-Asp-Gly) is evaluated for general respiratory epithelium stabilization. Similarly, broader immunomodulatory compounds like Thymosin Alpha-1 operate on systemic T-cell maturation rather than localized epithelial gene expression. For background on short-chain peptide signalers, review our guide to Khavinson peptides overview.
Proper handling and storage are critical to maintaining the structural integrity of synthetic Bronchogen during research trials. Lyophilized Bronchogen should be stored in a freezer at -20°C or -80°C away from light until reconstitution. Under these conditions, the dry peptide remains stable for extended periods.
For reconstituted in vitro assays, researchers typically dissolve the lyophilized powder in sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4). Avoid repeated freeze-thaw cycles by aliquoting the reconstituted solution into single-use working volumes. Detailed concentration calculations and solvent compatibility charts can be analyzed using our peptide reconstitution calculator.
PX1 Research enforces strict quality control standards for every batch of Bronchogen. Every lot undergoes independent, third-party laboratory verification using high-performance liquid chromatography (RP-HPLC) to verify purity exceeding 98% and electrospray ionization mass spectrometry (ESI-MS) to confirm exact molecular mass.
Additionally, all lots intended for cell culture studies undergo chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below strictly monitored research thresholds (<0.01 EU/mg). Review our standards on endotoxin testing standards to understand why low-endotoxin reagents are critical for cytokine quantification.
PX1 Research is dedicated to supporting academic institutions, biotechnology firms, and contract research organizations (CROs) with premium research reagents. Orders placed before 1:00 PM PST ship same-day from our California and Arizona logistics hubs to minimize supply chain delays for active study schedules.
To buy Bronchogen with verified purity specifications or request custom bulk quantities, visit the direct product page for Bronchogen. Institutional purchase orders, net terms, and batch reservation contracts are processed seamlessly through our specialized sales team.
What is the primary researched role of Bronchogen in cell culture models?
Bronchogen is primarily studied for its capacity to interact with DNA and modulate gene expression related to cellular repair and inflammatory cytokine secretion in bronchial epithelial cells.
Why does the price of Bronchogen vary among peptide vendors?
Pricing variations reflect differences in synthesis methods, chemical purity grade, scale, and the extent of quality testing. PX1 Research provides fully transparent pricing backed by third-party HPLC, MS, and endotoxin verification for every lot.
What solvents are recommended for reconstituting Bronchogen in laboratory settings?
Sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) are standard solvents for reconstituting lyophilized Bronchogen for in vitro research.
What purity level is required for cytokine regulation research using Bronchogen?
Studies measuring delicate gene expression and cytokine levels require a minimum purity of 98% by RP-HPLC to ensure residual synthesis chemicals do not skew assay results.
How should reconstituted Bronchogen solutions be stored?
Reconstituted solutions should be aliquoted to avoid freeze-thaw cycles and stored at -20°C or short-term at 4°C for up to 7-14 days depending on buffer stability.
Does PX1 Research provide Certificate of Analysis (COA) documents for Bronchogen?
Yes. Every shipment of Bronchogen from PX1 Research includes access to a lot-specific COA showing RP-HPLC purity profiles, mass spectrometry verification, and endotoxin test results.
Is Bronchogen approved for human consumption or therapeutic use?
No. Bronchogen supplied by PX1 Research is strictly designated for laboratory research use only and is not for human or animal therapeutic, diagnostic, or clinical applications.
What peptides are structurally or functionally similar to Bronchogen?
Peptides such as Chonluten (Glu-Asp-Gly) and Thymosin Alpha-1 are frequently studied alongside Bronchogen in respiratory tissue and immune response experimental setups.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.